DEA

In 2024, the cannabis landscape in the United States experienced some developments, though federal legalization or removal from the Controlled Substances Act (CSA) did not occur under the Biden administration, though that was promised to voters on a regular basis. “No one should be in jail...

U.S. authorities are reportedly investigating Chinese router manufacturer TP-Link as a possible threat to national security after multiple cyberattacks have been linked to the company's popular routers. What To Know: TP-Link is the top seller of routers on Amazon and holds about 65% of the U.S....

The long-awaited hearing to discuss cannabis rescheduling will begin on January 21, 2025, marking a significant moment in the ongoing debate over cannabis regulation. As Business of Cannabis reported, the six-week hearing will continue until March 6, 2025, but its outcome remains uncertain due to...

President-elect Donald Trump said Wednesday that he himself pulled out his initial pick to lead the Drug Enforcement Agency (DEA) despite the fact that Florida Sheriff Chad Chronister announced the day before that he was withdrawing from consideration. Nevertheless, Trump took to the airwaves...

Since 2015, U.S. taxpayers have allocated nearly $13 billion to international “counternarcotics” activities, including law enforcement, military support and punitive drug policies.  According to a report by Harm Reduction International (HRI) and the Drug Policy Alliance (DPA), this...

In a recent note, senior analyst Pablo Zuanic digs into the financial standing and valuation of Village Farms (NASDAQ:VFF), the only cannabis company anointed by the Drug Enforcement Agency (DEA) as one of the 25 DPs ("designated participants") in the administrative hearing for the rescheduling of...

President-elect Donald Trump's choice to lead the Drug Enforcement Administration announced on Tuesday he is withdrawing from consideration just three days after Trump made his nomination known, reported the Associated Press. Chad Chronister, Florida's Hillsborough County Sheriff, said in a post on...

Nebraska's Government is fighting cannabis reform both at the local and federal level. State Attorney General Mike Hilgers recently filed an amended cross-claim on behalf of Secretary of State Bob Evnen in a lawsuit challenging two successful medical cannabis measures. This move formally introduces...

The Drug Enforcement Administration (DEA) launched its inaugural hearing on Monday December 2, 2024, to address the Biden administration's proposal to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). According to a DEA advisory released on November 26...

President-elect Donald Trump's recent nominations for key law enforcement roles suggest a pivot in federal drug enforcement with potential ramifications for cannabis legalization policy. Trump nominated Kash Patel, a former national security official, to lead the FBI and Chad Chronister, a Florida...

As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. With the DEA hearing delayed until early 2025 and a possible Trump presidency adding uncertainty, cannabis businesses are preparing for what rescheduling to...

When the Drug Enforcement Administration marked its 50th anniversary last year, it had spent over $1 trillion partly to enforce Richard Nixon's 1970 Controlled Substances Act, the cornerstone of his War on Drugs, which is widely viewed as a failure. Now, doesn't this sound like the type of...

Smart Approaches to Marijuana (SAM), an active prohibitionist group, has denied allegations of improper communications with the Drug Enforcement Administration (DEA) ahead of next week’s cannabis rescheduling hearing. SAM's Nov. 25 legal response dismissed the claims as unfounded and aimed...

The Drug Enforcement Administration (DEA) has denied accusations of improper communication with cannabis prohibitionist group Smart Approaches to Marijuana (SAM) during the Biden administration's marijuana rescheduling process. In a recent filing reported by Marijuana Moment, the agency dismissed...

A DEA administrative law judge has denied MedPharm's motion to participate in the December 2 marijuana rescheduling hearing, deferring to DEA Administrator Anne Milgram's authority. MedPharm, a DEA-registered research firm, criticized the exclusion of marijuana researchers and the inclusion of...